LGRNX
Price
$23.66
Change
+$0.11 (+0.47%)
Updated
Dec 8, 6:59 PM EST
RGACX
Price
$62.61
Change
+$0.43 (+0.69%)
Updated
Dec 8, 6:59 PM EST
Ad is loading...

Compare trend and price LGRNX vs RGACX

Header iconLGRNX vs RGACX Comparison
Open Charts LGRNX vs RGACXBanner chart's image
Loomis Sayles Growth N
Price$23.66
Change+$0.11 (+0.47%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R3
Price$62.61
Change+$0.43 (+0.69%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LGRNX vs RGACX Comparison Chart

Loading...

VS
LGRNX vs. RGACX commentary
Dec 11, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRNX is a Buy and RGACX is a Buy.

FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 214B vs. LGRNX (12B). LGRNX (0.00) and RGACX (0.00) have matching dividends . LGRNX was incepted earlier than RGACX: LGRNX (11 years) vs RGACX (22 years). RGACX (0.94) is less costly to investors than LGRNX (0.57). RGACX is a more actively managed with annual turnover of: 31.00 vs. LGRNX (20.00). RGACX has a lower initial minimum investment than LGRNX: RGACX (250) vs LGRNX (1000000). RGACX annual gain was more profitable for investors over the last year : 20.71 vs. LGRNX (19.49). LGRNX return over 5 years is better than : 54.04 vs. RGACX (33.53).
LGRNXRGACXLGRNX / RGACX
Total Expense Ratio0.570.9461%
Annual Report Gross Expense Ratio0.570.9461%
Fund Existence11 years22 years-
Gain YTD45.15330.139150%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12B214B6%
Annual Yield % from dividends0.000.00-
Returns for 1 year19.4920.7194%
Returns for 3 years-1.13-3.0237%
Returns for 5 years54.0433.53161%
Returns for 10 years180.42118.43152%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CFCV34.530.09
+0.26%
Clearbridge Focus Value ESG ETF
OCTW32.330.06
+0.17%
AllianzIM US Large Cap Buffer20 Oct ETF
AOR51.83N/A
N/A
iShares Core Growth Allocation ETF
HQL12.44N/A
N/A
abrdn Life Sciences Investors
IBHH22.81-0.06
-0.26%
iShares iBonds 2028 Term HY & Inc ETF